Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
-37.84%
1 Year
-37.84%
2 Year
-96.88%
Key data
Company detail
CEO:
Region: US
Website: sqzbiotech.com
Employees: 53
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:
Region: US
Website: sqzbiotech.com
Employees: 53
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:
spun out of mit, sqz biotechnologies is developing the next generation of cell therapies, using its propriety technology to harness the power of the patient's immune system to combat disease. sqz: empower cells to change lives.
Recent news